PRA Health Sciences Late Phase Services is participating in a global real world safety study program, mandated by various regulatory bodies, to confirm risk/benefit profile for a novel oral anticoagulant to assess the drug’s bleeding risk. Our ability to provide global operational oversight and efficiencies, ensure consistent communication with sites, and keep our patients engaged resulted in PRA becoming the client’s CRO of choice.
Explore related content and topics
Fact Sheet
Real World Solutions
PRA Health Sciences’ Real World Solutions team guides clients through the intricacies of real world research throughout the development life cycle.…
View Resource
Webcast
THE INSIGHT SERIES: Do Late Phase Studies Offer Any Scientific Value? – Part 2
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…
View Resource
Blog
Bridging Recruitment Gaps with Academic Collaboration
Read Story
View all related content and resources for Real World Solutions
Explore Insights